First Header Logo Second Header Logo

Connection

Christopher Ohl to Vancomycin

This is a "connection" page, showing publications Christopher Ohl has written about Vancomycin.
Connection Strength

0.455
  1. Liu P, Ohl C, Johnson J, Williamson J, Beardsley J, Luther V. Frequency of empiric antibiotic de-escalation in an acute care hospital with an established Antimicrobial Stewardship Program. BMC Infect Dis. 2016 Dec 12; 16(1):751.
    View in: PubMed
    Score: 0.142
  2. Williamson JC, Gibbs HG, Ohl CA, Johnson JW, Beardsley JR, Luther VP, Rokas KE. Reply to Young, Ochi, and Marimuthu. Clin Infect Dis. 2016 Mar 15; 62(6):810-1.
    View in: PubMed
    Score: 0.132
  3. Rokas KE, Johnson JW, Beardsley JR, Ohl CA, Luther VP, Williamson JC. The Addition of Intravenous Metronidazole to Oral Vancomycin is Associated With Improved Mortality in Critically Ill Patients With Clostridium difficile Infection. Clin Infect Dis. 2015 Sep 15; 61(6):934-41.
    View in: PubMed
    Score: 0.127
  4. Moyenuddin M, Ohl CA, Williamson JC, Peacock JE. Disseminated oxacillin-resistant Staphylococcus aureus infection responsive to vancomycin and quinupristin-dalfopristin combination therapy. J Antimicrob Chemother. 2003 Jan; 51(1):202-3.
    View in: PubMed
    Score: 0.054
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.